首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Group cognitive behavior therapy for bipolar disorder can improve the quality of life
【24h】

Group cognitive behavior therapy for bipolar disorder can improve the quality of life

机译:躁郁症的集体认知行为疗法可以改善生活质量

获取原文
获取外文期刊封面目录资料

摘要

Bipolar disorder (BD) can have an impact on psychosocial functioning and quality of life (QoL). Several studies have shown that structured psychotherapy in conjunction with pharmacotherapy may modify the course of some disorders; however, few studies have investigated the results of group cognitive behavior therapy (G-CBT) for BD. Our objective was to evaluate the effectiveness of 14 sessions of G-CBT for BD patients, comparing this intervention plus pharmacotherapy to treatment as usual (TAU; only pharmacotherapy). Forty-one patients with BD I and II participated in this study and were randomly allocated to each group (G-CBT: N = 27; TAU: N = 14). Thirty-seven participants completed the treatment (women: N = 66.67%; mean age = 41.5 years). QoL and mood symptoms were assessed in all participants. Scores changed significantly by the end of treatment in favor of the G-CBT group. The G-CBT group presented significantly better QoL in seven of the eight sub-items assessed with the Medical Outcomes Survey SF-36 scale. At the end of treatment, the G-CBT group exhibited lower scores for mania (not statistically significant) and depression (statistically significant) as well as a reduction in the frequency and duration of mood episodes (P < 0.01). The group variable was significant for the reduction of depression scores over time. This clinical change may explain the improvement in six of the eight subscales of QoL (P < 0.05). The G-CBT group showed better QoL in absolute values in all aspects and significant improvements in nearly all subscales. These results were not observed in the TAU control group.
机译:躁郁症(BD)可能会影响社会心理功能和生活质量(QoL)。多项研究表明,有组织的心理治疗结合药物治疗可能会改变某些疾病的病程。然而,很少有研究调查针对BD的群体认知行为疗法(G-CBT)的结果。我们的目的是评估14疗程的G-CBT对BD患者的有效性,将这种干预加上药物治疗与常规治疗进行比较(TAU;仅药物治疗)。 BD I和II的41位患者参加了这项研究,并随机分配到每组(G-CBT:N = 27; TAU:N = 14)。三十七名参与者完成了治疗(妇女:N = 66.67%;平均年龄= 41.5岁)。对所有参与者的生活质量和情绪症状进行了评估。到治疗结束时,得分明显改变,转而支持G-CBT组。 G-CBT组在用医学成果调查SF-36量表评估的八个子项目中的七个中表现出明显更好的QoL。在治疗结束时,G-CBT组表现出较低的躁狂评分(无统计学意义)和抑郁评分(统计显着意义),以及情绪发作的频率和持续时间的减少(P <0.01)。组变量对于随着时间的推移抑郁评分的降低具有重要意义。这种临床变化可以解释QoL八个分量表中六个分量表的改善(P <0.05)。 G-CBT组在所有方面的绝对值均表现出更好的QoL,并且在几乎所有子量表中均取得了显着改善。在TAU对照组中未观察到这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号